PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis.
CD10
PAX8
extragenital endometriosis
marker
Journal
Reproductive sciences (Thousand Oaks, Calif.)
ISSN: 1933-7205
Titre abrégé: Reprod Sci
Pays: United States
ID NLM: 101291249
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
pubmed:
21
5
2020
medline:
15
12
2020
entrez:
21
5
2020
Statut:
ppublish
Résumé
In cases of extragenital endometriosis or microscopic endometriosis lesions, pathological diagnosis can be challenging because endometriotic stroma and glands represent only a minor component of fibrotic endometriotic lesions. For better accuracy of diagnosis, the development of a sensitive and specific epithelial marker is beneficial. Previous studies showed that PAX8 is a highly sensitive and specific marker for primary and metastatic Mullerian epithelial tumors. Therefore, we sought to examine whether PAX8 is a highly sensitive marker for glands in extragenital endometriosis. Eight and 47 samples of ovarian endometrioma and extragenital endometriosis, respectively, were evaluated in this study. We calculated the percentage of samples positively immunostained for PAX8, CD10, estrogen receptor (ER), and progesterone receptor (PR). PAX8 was positive for endometriotic epithelial cells in 95.7% (45/47) of extragenital endometrioses and in 100% (8/8) of ovarian endometrioses. CD10 was positive for endometriotic stromal cells in 97.9% (46/47) of extragenital endometrioses. PAX8 was strongly positive for glands, even in a CD10-negative case. The expression of PAX8, CD10, and PR was not affected by preoperative hormonal therapy, and the positive rate of ER staining was significantly reduced by preoperative hormonal therapy. In conclusion, PAX8 is a highly sensitive epithelial marker for extragenital endometriosis. This specific expression was maintained under hormonal therapy. It is noteworthy that extragenital endometriosis maintains the expression of this lineage marker, although it occurs at various sites, and its cause and mechanism of development might be different. PAX8 nuclear expression can be useful in detecting extragenital endometriosis in clinical practice.
Identifiants
pubmed: 32430717
doi: 10.1007/s43032-020-00186-7
pii: 10.1007/s43032-020-00186-7
doi:
Substances chimiques
Biomarkers
0
PAX8 Transcription Factor
0
PAX8 protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1580-1586Références
Zondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Vigano P. Endometriosis. Nat Rev Dis Primers. 2018;4(1):9.
pubmed: 30026507
pmcid: 30026507
doi: 10.1038/s41572-018-0008-5
Sumathi VP, McCluggage WG. CD10 is useful in demonstrating endometrial stroma at ectopic sites and in confirming a diagnosis of endometriosis. J Clin Pathol. 2002;55(5):391–2.
pubmed: 11986349
pmcid: 11986349
doi: 10.1136/jcp.55.5.391
Potlog-Nahari C, Feldman AL, Stratton P, et al. CD10 immunohistochemical staining enhances the histological detection of endometriosis. Fertil Steril. 2004;82(1):86–92.
pubmed: 15236994
pmcid: 15236994
doi: 10.1016/j.fertnstert.2003.11.059
Vigano P, Candiani M, Monno A, Giacomini E, Vercellini P, Somigliana E. Time to redefine endometriosis including its profibrotic nature. Hum Reprod. 2018;33(3):347–52.
pubmed: 29206943
pmcid: 29206943
doi: 10.1093/humrep/dex354
Noe M, Ayhan A, Wang TL, Shih IM. Independent development of endometrial epithelium and stroma within the same endometriosis. J Pathol. 2018;245(3):265–9.
pubmed: 29604057
doi: 10.1002/path.5082
Mansouri A, Hallonet M, Gruss P. Pax genes and their roles in cell differentiation and development. Curr Opin Cell Biol. 1996;8(6):851–7.
pubmed: 8939674
doi: 10.1016/S0955-0674(96)80087-1
Dahl E, Koseki H, Balling R. Pax genes and organogenesis. Bioessays. 1997;19(9):755–65.
pubmed: 9297966
doi: 10.1002/bies.950190905
Plachov D, Chowdhury K, Walther C, Simon D, Guenet JL, Gruss P. Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland. Development. 1990;110(2):643–51.
pubmed: 1723950
Poleev A, Fickenscher H, Mundlos S, et al. PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms’ tumors. Development. 1992;116(3):611–23.
pubmed: 1337742
Mittag J, Winterhager E, Bauer K, Grummer R. Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy. Endocrinology. 2007;148(2):719–25.
pubmed: 17082261
doi: 10.1210/en.2006-1054
Laury AR, Perets R, Piao H, et al. A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol. 2011;35(6):816–26.
pubmed: 21552115
doi: 10.1097/PAS.0b013e318216c112
Ozcan A, Liles N, Coffey D, Shen SS, Truong LD. PAX2 and PAX8 expression in primary and metastatic Mullerian epithelial tumors: a comprehensive comparison. Am J Surg Pathol. 2011;35(12):1837–47.
pubmed: 21989345
doi: 10.1097/PAS.0b013e31822d787c
Ozcan A, Shen SS, Hamilton C, et al. PAX 8 expression in nonneoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study. Mod Pathol. 2011;24(6):751–64.
pubmed: 21317881
doi: 10.1038/modpathol.2011.3
OrdonezNG. Value of PAX8 immunostaining in tumor diagnosis: a review and update. Adv Anat Pathol. 2012;19(3):140-151.
Haga T, Kumasaka T, Kurihara M, Kataoka H, Miura M. Immunohistochemical analysis of thoracic endometriosis. Pathol Int. 2013;63(9):429–34.
pubmed: 24200154
Al-Khawaja M, Tan PH, MacLennan GT, Lopez-Beltran A, Montironi R, Cheng L. Ureteral endometriosis: clinicopathological and immunohistochemical study of 7 cases. Hum Pathol. 2008;39(6):954–9.
pubmed: 18538172
doi: 10.1016/j.humpath.2007.11.011
Donnez J, Nisolle M, Casanas-Roux F, Brion P, Da Costa Ferreira N. Stereometric evaluation of peritoneal endometriosis and endometriotic nodules of the rectovaginal septum. Hum Reprod. 1996;11(1):224–8.
pubmed: 8671191
doi: 10.1093/oxfordjournals.humrep.a019024
Zanatta A, Pereira RM, Rocha AM, et al. The relationship among HOXA10, estrogen receptor alpha, progesterone receptor, and progesterone receptor B proteins in rectosigmoid endometriosis: a tissue microarray study. Reprod Sci. 2015;22(1):31–7.
pubmed: 25217304
pmcid: 4527422
doi: 10.1177/1933719114549846
Colon-Caraballo M, Garcia M, Mendoza A, Flores I. Human endometriosis tissue microarray reveals site-specific expression of estrogen receptors, progesterone receptor, and Ki67. Appl Immunohistochem Mol Morphol. Epub ahead of print 7 April 2018.
Haga T, Kurihara M, Kataoka H, Ebana H. Clinical-pathological findings of catamenial pneumothorax: comparison between recurrent cases and non-recurrent cases. Ann Thorac Cardiovasc Surg. 2014;20(3):202–6.
pubmed: 23698374
doi: 10.5761/atcs.oa.12.02227
Gomes MK, Rosa-e-Silva JC, Garcia SB, et al. Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium. Hum Reprod. 2009;24(11):2736–45.
pubmed: 19661125
doi: 10.1093/humrep/dep288
Kitano T, Matsumoto T, Takeuchi H, et al. Expression of estrogen and progesterone receptors in smooth muscle metaplasia of rectovaginal endometriosis. Int J Gynecol Pathol. 2007;26(2):124–9.
pubmed: 17413977
doi: 10.1097/01.pgp.0000235067.16054.dd
Ma D, Marion R, Punjabi NP, et al. A de novo 10.79 Mb interstitial deletion at 2q13q14.2 involving PAX8 causing hypothyroidism and Mullerian agenesis: a novel case report and literature review. Mol Cytogenet. 2014;7(1):85.